Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis

Scand J Rheumatol. 2018 May;47(3):248-250. doi: 10.1080/03009742.2017.1297482. Epub 2017 May 8.

Authors

M Kono¹, S Yasuda¹, M Kono¹, T Atsumi¹

Affiliation

¹ a Division of Rheumatology, Endocrinology and Nephrology , Hokkaido University Graduate School of Medicine , Sapporo , Japan.

PMID: 28480784
DOI: 10.1080/03009742.2017.1297482

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Citrullinated Protein Antibodies / biosynthesis
Anti-Citrullinated Protein Antibodies / drug effects
Anti-Citrullinated Protein Antibodies / immunology*
Antibodies, Monoclonal, Humanized / therapeutic use*
Arthritis, Rheumatoid / blood
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / immunology
Autoantibodies / biosynthesis
Autoantibodies / drug effects
Autoantibodies / immunology*
Female
Humans
Male
Scleroderma, Systemic / blood
Scleroderma, Systemic / drug therapy*
Scleroderma, Systemic / immunology

Substances

Anti-Citrullinated Protein Antibodies
Antibodies, Monoclonal, Humanized
Autoantibodies
tocilizumab